https://www.vesicahealth.com/news-1/vesica-health-receives-fda-breakthrough-device-designation-for-assuremdx 2026-02-26 https://www.vesicahealth.com/news-1/vesica-health-granted-pla-billing-code-for-assuremdx 2025-10-01 https://www.vesicahealth.com/news-1/vesica-health-receives-aua-guideline-inclusion 2025-09-15 https://www.vesicahealth.com/news-1/american-urological-association-announces-2025-innovation-nexus-showcase-selections 2025-02-12 https://www.vesicahealth.com/news-1/vesica-health-secures-cap-accreditation%2C-advancing-leadership-in-bladder-cancer-detection 2025-01-07 https://www.vesicahealth.com/news-1/vesica-health-announces-formation-of-scientific-advisory-board 2025-01-06 https://www.vesicahealth.com/news-1/vesica-health-announces-launch-of-assuremdx-test-to-improve-bladder-cancer-detection 2025-01-07 https://www.vesicahealth.com/news-1/vesica-health's-assuremdx%3A-revolutionizing-surveillance-for-bladder-cancer-patients 2024-03-27 https://www.vesicahealth.com/news-1/vesica-health-to-present-at-the-seed-showcase%2C-part-of-biotech-showcase%2C-the-investor-conference-for-innovators 2024-01-02 https://www.vesicahealth.com/news-1/vesica-health-appoints-distinguished-urologic-oncologist-dr.-william-t.-lowrance-to-chief-medical-officer 2025-01-06 https://www.vesicahealth.com/news-1/vesica-health-announces-publication-of-study-demonstrating-assuremdx-meaningfully-improves-identification-of-hematuria-patients-at-high-risk-for-bladder-cancer 2025-01-06 https://www.vesicahealth.com/news-1/vesica-health-announces-the-appointment-of-recognized-industry-leaders-to-newly-formed-board-of-directors 2025-01-06